176 related articles for article (PubMed ID: 38433139)
1. Trisomy 21-driven metabolite alterations are linked to cellular injuries in Down syndrome.
Liu J; Chen S; Huang G; Wen P; Zhou X; Wu Y
Cell Mol Life Sci; 2024 Mar; 81(1):112. PubMed ID: 38433139
[TBL] [Abstract][Full Text] [Related]
2. Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels.
Murray A; Gough G; Cindrić A; Vučković F; Koschut D; Borelli V; Petrović DJ; Bekavac A; Plećaš A; Hribljan V; Brunmeir R; Jurić J; Pučić-Baković M; Slana A; Deriš H; Frkatović A; Groet J; O'Brien NL; Chen HY; Yeap YJ; Delom F; Havlicek S; Gammon L; Hamburg S; Startin C; D'Souza H; Mitrečić D; Kero M; Odak L; Krušlin B; Krsnik Ž; Kostović I; Foo JN; Loh YH; Dunn NR; de la Luna S; Spector T; Barišić I; Thomas MSC; Strydom A; Franceschi C; Lauc G; Krištić J; Alić I; Nižetić D
EBioMedicine; 2023 Aug; 94():104692. PubMed ID: 37451904
[TBL] [Abstract][Full Text] [Related]
3. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.
Murray A; Letourneau A; Canzonetta C; Stathaki E; Gimelli S; Sloan-Bena F; Abrehart R; Goh P; Lim S; Baldo C; Dagna-Bricarelli F; Hannan S; Mortensen M; Ballard D; Syndercombe Court D; Fusaki N; Hasegawa M; Smart TG; Bishop C; Antonarakis SE; Groet J; Nizetic D
Stem Cells; 2015 Jun; 33(6):2077-84. PubMed ID: 25694335
[TBL] [Abstract][Full Text] [Related]
4. Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression.
Mowery CT; Reyes JM; Cabal-Hierro L; Higby KJ; Karlin KL; Wang JH; Kimmerling RJ; Cejas P; Lim K; Li H; Furusawa T; Long HW; Pellman D; Chapuy B; Bustin M; Manalis SR; Westbrook TF; Lin CY; Lane AA
Cell Rep; 2018 Nov; 25(7):1898-1911.e5. PubMed ID: 30428356
[TBL] [Abstract][Full Text] [Related]
5. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome.
Aivazidis S; Coughlan CM; Rauniyar AK; Jiang H; Liggett LA; Maclean KN; Roede JR
PLoS One; 2017; 12(4):e0176307. PubMed ID: 28430800
[TBL] [Abstract][Full Text] [Related]
6. iPSC-derived progenitor stromal cells provide new insights into aberrant musculoskeletal development and resistance to cancer in down syndrome.
Galat Y; Perepitchka M; Elcheva I; Iannaccone S; Iannaccone PM; Galat V
Sci Rep; 2020 Aug; 10(1):13252. PubMed ID: 32764607
[TBL] [Abstract][Full Text] [Related]
7. Trisomy correction in Down syndrome induced pluripotent stem cells.
Li LB; Chang KH; Wang PR; Hirata RK; Papayannopoulou T; Russell DW
Cell Stem Cell; 2012 Nov; 11(5):615-9. PubMed ID: 23084023
[TBL] [Abstract][Full Text] [Related]
8. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
9. Generation of integration-free Down syndrome and isogenic euploid human induced pluripotent stem cells.
Nehra S; Sharma V; Umrani M; Singhal N
Stem Cell Res; 2023 Mar; 67():103041. PubMed ID: 36764067
[TBL] [Abstract][Full Text] [Related]
10. Perturbations of heart development and function in cardiomyocytes from human embryonic stem cells with trisomy 21.
Bosman A; Letourneau A; Sartiani L; Del Lungo M; Ronzoni F; Kuziakiv R; Tohonen V; Zucchelli M; Santoni F; Guipponi M; Dumevska B; Hovatta O; Antonarakis SE; Jaconi ME
Stem Cells; 2015 May; 33(5):1434-46. PubMed ID: 25645121
[TBL] [Abstract][Full Text] [Related]
11. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.
Briggs JA; Sun J; Shepherd J; Ovchinnikov DA; Chung TL; Nayler SP; Kao LP; Morrow CA; Thakar NY; Soo SY; Peura T; Grimmond S; Wolvetang EJ
Stem Cells; 2013 Mar; 31(3):467-78. PubMed ID: 23225669
[TBL] [Abstract][Full Text] [Related]
12. [Progress of research on induced pluripotent stem cell models for Down syndrome].
Zhang T; Kong L; Sun G; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1183-1185. PubMed ID: 32924131
[TBL] [Abstract][Full Text] [Related]
13. Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain.
Farley SJ; Grishok A; Zeldich E
Epigenetics Chromatin; 2022 Dec; 15(1):39. PubMed ID: 36463299
[TBL] [Abstract][Full Text] [Related]
14. Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel.
Lana-Elola E; Watson-Scales S; Slender A; Gibbins D; Martineau A; Douglas C; Mohun T; Fisher EM; Tybulewicz VL
Elife; 2016 Jan; 5():. PubMed ID: 26765563
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells.
Hibaoui Y; Feki A
J Clin Med; 2015 Apr; 4(4):696-714. PubMed ID: 26239351
[TBL] [Abstract][Full Text] [Related]
16. Meiotic behavior of aneuploid chromatin in mouse models of Down syndrome.
Reinholdt LG; Czechanski A; Kamdar S; King BL; Sun F; Handel MA
Chromosoma; 2009 Dec; 118(6):723-36. PubMed ID: 19639331
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors.
Laan L; Klar J; Sobol M; Hoeber J; Shahsavani M; Kele M; Fatima A; Zakaria M; Annerén G; Falk A; Schuster J; Dahl N
Clin Epigenetics; 2020 Jan; 12(1):9. PubMed ID: 31915063
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic signature of major congenital heart defects in newborns with Down syndrome.
Mouat JS; Li S; Myint SS; Laufer BI; Lupo PJ; Schraw JM; Woodhouse JP; de Smith AJ; LaSalle JM
Hum Genomics; 2023 Oct; 17(1):92. PubMed ID: 37803336
[TBL] [Abstract][Full Text] [Related]
19. Generation of two human iPSC lines (UUIGPi013-A and UUIPGi014-A) from cases with Down syndrome and full trisomy for chromosome 21 (T21).
Schuster J; Hoeber J; Sobol M; Fatima A; Annerén G; Dahl N
Stem Cell Res; 2020 Dec; 49():102081. PubMed ID: 33220594
[TBL] [Abstract][Full Text] [Related]
20. Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts.
Necchi D; Pinto A; Tillhon M; Dutto I; Serafini MM; Lanni C; Govoni S; Racchi M; Prosperi E
Mutat Res; 2015 Oct; 780():15-23. PubMed ID: 26258283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
